| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA617: Lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure |
|
Medicine details |
|
| Medicine name | lusutrombopag (Mulpleo®) |
| Formulation | 3 mg film-coated tablet |
| Reference number | 3786 |
| Indication | Treatment of severe thrombocytopenia in adult patients with chronic liver disease undergoing invasive procedures |
| Company | Shionogi Ltd |
| BNF chapter | Nutrition & blood |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 29/05/2019 |
| NICE guidance | |